Longer duration of anticoagulation reduces the risk of recurrence of venous thromboembolism
Caroline Barranco
This article has no abstract so we have provided the first paragraph of the full text.
The optimal duration of anticoagulation for patients with venous thromboembolism (VTE) remains controversial. Previous studies, and even meta-analyses, have come to conflicting conclusions on the risks and benefits of prolonging anticoagulation in these patients.
Full text of this article is available with one of the following:
- Personal subscription Purchase your own personal subscription to this journal. Already a subscriber? Please log in for immediate access.
- 7 day single article pass for US$18 In order to purchase this article you must be a registered user. Please register or log in.
- Site licence Learn more about institutional site licences
Current Subscribers
Please log in to access the full text article using the login box at the top of the page.
